Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

The FTC accuses major PBMs of inflating insulin prices, impacting patient costs and access to affordable medications. PBMs prioritize high-rebate drugs, contributing to high insulin prices and ...

Cigna is following through on promises to more aggressively defend its pharmacy benefit manager. On Tuesday, the healthcare company’s PBM, Express Scripts, sued the Federal Trade Commission over the ...

Express Scripts has filed suit against the Federal Trade Commission (FTC), demanding that the agency retract a damning report on the pharmacy benefit management industry. In the lawsuit, which was ...

The potential deal comes about a year and a half after the FTC first brought the case against Express Scripts, CVS’ Caremark and UnitedHealth’s Optum Rx. If approved, the agreement would mark the ...

Express Scripts, the pharmacy benefits management business of the Cigna Group's Evernorth, will add three additional biosimilars to its National Preferred Formulary that it said will compete with ...

When Michael Holmes presented the idea to spin off the RX Outreach prescription assistance program from Express Scripts as a separate not-for-profit organization, he thought it was the right strategic ...

BLOOMFIELD, Conn.--(BUSINESS WIRE)-- Global health service company Cigna (NYSE: CI) and its Express Scripts unit are helping residents of Florida affected by Hurricane Dorian by easing some health ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

Another major pharmacy benefit manager is adding Humira biosimilars to its formulary beginning next year. Express Scripts, which is part of Cigna's Evernorth subsidiary, said Monday that it will add ...

Pharmacy benefit manager Express Scripts, part of Cigna's Evernorth subsidiary, will be adding Humira biosimilars to its formulary in 2023 as preferred products, which will be available to patients ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...